-+ 0.00%
-+ 0.00%
-+ 0.00%

Newbury Pharmaceuticals agrees to increase loan from Slädens Pensionsstiftelse nr 3 to SEK 40 million

PUBT·11/18/2026 17:28:27
Listen to the news
Newbury Pharmaceuticals agrees to increase loan from Slädens Pensionsstiftelse nr 3 to SEK 40 million
  • Newbury Pharmaceuticals agreed with Slädens Pensionsstiftelse nr 3 to increase its loan by SEK 10 million to SEK 40 million.
  • The amendment extends maturity by one year to June 30, 2028, subject to shareholder approval on January 20, 2027.
  • Interest remains at 11% annually, payable quarterly.
  • Early repayment, in whole or part, will be permitted on 30 days' notice without a prepayment fee.
  • The lender expressed nonbinding interest in converting SEK 10-15 million into shares through set-off if a share issue proceeds.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Newbury Pharmaceuticals AB published the original content used to generate this news brief on November 18, 2026, and is solely responsible for the information contained therein.